Publications

Collaborators and clients must trust
the companies with whom they work

Collaborators and clients must trust companies with whom they work and have true evidence of the quality, credibility, value and track record of their services.

For more than two decades, AXDEV has provided the evidence to ensure quality and trust with our collaborators and clients. We have contributed to shaping the evolution of education, performance improvement and implementation research in healthcare and corporate environments around the world.

With our collaborators, clients and stakeholders, we have been recognized in more than 200 peer-reviewed publications and have earned numerous awards.

Our accomplishments are your successes!

Our publications

Search filters

Clear all filters

Showing 1 to 9 of 255 entries

CONFERENCE

AIS (Alliance Industry Summit) 2024

At this year’s AIS conference in Philadelphia, on September 17, 2024, AXDEV CEO & Founder, Suzanne Murray, presented and explored best practices, and errors, in Needs Assessment, that best inform Instructional Design and Program Evaluation.

This was a very engaging session, where the audience was invited to interact and learn more about this topic.

  • CME/CPD
  • N/A
  • 2024
CONFERENCE

Showcasing Success:  Disseminating Your Work Matters

ACEHP (Alliance for Continuing Education in the Health Professions) September 12, 2024

This webinar addressed how to effectively disseminate your education and research through various channels (journals, professional societies, social media).

Presenters included our CEO & Founder, Suzanne Murray, Jacob Coverstone, David Price, Erin Schwarz, with our moderator Riaz Baxamusa

  • PERFORMANCE IMPROVEMENT
  • N/A
  • 2024
ARTICLE

Multidisciplinary Education and Action to Foster Equitable Cancer Care

Accepted for presention at the 2023 ASCO Quality of Care Symposium in Boston on October 27-28, 2023.

  • CME/CPD
  • ONCO
  • 2023
ARTICLE

Knowledge, skills, and confidence gaps impacting treatment decision making in relapsed/refractory chronic lymphocytic leukemia and mantle cell lymphoma: a quantitative survey study in France,Germany, and the United States

Published in BMC Cancer: Open access journal for cancer research.

This study was financially supported by educational research funds from
Eli Lilly & Company

  • NEEDS ASSESSMENT
  • ONCO
  • 2024
CONFERENCE

Why are we only talking about OUTCOMES, when we should also be talking about IMPACT?

Accepted for presentation at the 17th Annual European CME Forum, 6–8 November, 2024 in Madrid, Spain.

  • CME/CPD
  • N/A
  • 2024
CONFERENCE

Recognizing clinical manifestations of rare diseases: Knowledge and confidence gaps of HCPs can impact diagnosis and management of Fibrodysplasia Ossificans Progressiva (FOP)

Accepted for presentation at the 2024 NORD Rare Diseases & Orphan Products Breakthrough Summit, October 20-22 2024 in Washington DC.

  • CME/CPD
  • Rare Diseases
  • 2024
CONFERENCE

Adaptive learning to address gaps in metastatic breast cancer treatment with CDK 4/6 inhibitors

Accepted for presentation at ASCO 2024 Quality Care Symposium in San Francisco on September 27-28.

Project was in collaboration with Antidote Education and funded by Pfizer

  • CME/CPD
  • ONCO
  • 2024
ARTICLE

Use of non‐invasive diagnostic tools for metabolic dysfunction‐associated steatohepatitis: A qualitative exploration of challenges and barriers

Published in Liver International.

This project was supported through independent educational research funds from Pfizer.

  • NEEDS ASSESSMENT
  • Hepatology
  • 2024
CONFERENCE

Impact of a PD-L1 Learning Collaborative: outcomes from a mixed-methods evaluation

Accepted for the annual meeting of the American Society for Clinical Pathology (ASCP), which will take place in Chicago, IL, September 3-6, 2024.

  • PROGRAM EVALUATION
  • ONCO
  • 2024